Biotech director: ensure opportunities include signed survey fees

Biotech directors risk missing signed acceptances and agreed survey fees, creating billing delays. So sales reps have the fee and signature on the opportunity to start billing and approvals.

Overview

Signed acceptance forms and unrecorded survey fees create billing risk and stalled approvals for biotech deals. This workflow ensures every accepted fee and signature land on the CRM opportunity so sales reps can start billing and approvals without gaps. Customers report faster handoffs and fewer billing errors.

Notable Features

Attach signature to opportunity record
Update opportunity with survey fee
Notify sales reps of updates